SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Clinuvel Pharmaceuticals Ltd
An SI Board Since December 2004
Posts SubjectMarks Bans Symbol
52 3 0 CLVLY
Emcee:  caly Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
27There's some discussion about this on the SRDX board on iHub. Regards, DewDewDiligence_on_SI-7/13/2010
26Phase III Results for EPP clinuvel.com Business Week coverage on this news: bcaly-7/13/2010
25SurModics Signs License Agreement with Clinuvel Pharmaceuticals SRDX 16.38 +0.1caly-7/8/2010
24Company Announcement Tuesday 18th May 2010 Melbourne, Australia Clinuvel unveilcaly-5/17/2010
23Tuesday, March 30, 2010 Clinuvel Pharmaceuticals gets FDA approval for light icaly-3/30/2010
22CLINUVEL ANNOUNCES POSITIVE PHASE III INTERIM RESULTS FOR EPP clinuvel.comcaly-1/20/2009
21ABN Amro report... clinuvel.comcaly-1/5/2009
20I'd be more concerned about tanning salon owners. If people will go to thatcaly-3/14/2008
19What happens to sunblock vendors if this drug is approved?DewDiligence_on_SI-3/14/2008
18Clinuvel granted orphan drug status by EMEA: news.smh.com.au ABN Amro commentscaly-3/14/2008
17ABN Amro Equities Australia Report: clinuvel.com.aucaly-8/30/2007
16June 2007 Newsletter ept.irmau.comcaly-7/3/2007
15Phase III trial of CUV1647 begins in Polymorphic Light Eruption Monday 21st Maycaly-5/30/2007
14Clinuvel completes A$26 million Private Placement and announces a Share Purchasecaly-4/26/2007
13Clinuvel receives approval to begin Phase III trials in a second indication – EPcaly-4/11/2007
12Clinuvel UK approval for Phase 3 trial 10:02, Wednesday, 31 January 2007 Sydnecaly-1/30/2007
11Clinuvel receives approval to begin Phase III trials Wednesday 24th January 200caly-1/23/2007
10Aussie discussion: sharescene.comcaly-11/17/2006
9Monday 7 March 2005 EpiTan receives ethics approval for Phase II “Endpoint” stucaly-3/6/2005
8Tuesday 1 March 2005 PMLE trial of Melanotan ® to start in Finland EpiTancaly-2/28/2005
7EpiTan files for full international patent for sustained release EpiTan Limitedcaly-2/13/2005
6<b>Intersuisse Research Report</b> epitan.com.au EpiTan 25 Januarycaly-1/27/2005
5Monday 24 January 2005 EpiTan appoints Regulatory Affairs Manager EpiTan Limitcaly-1/23/2005
4Friday 21 January 2005 Dr Wayne Millen retires as CEO of EpiTan Iain Kirkwood caly-1/20/2005
3Sun Protection in a Pill Seen Possible Mon Jan 10, 6:19 PM ET Health - Reutercaly-1/11/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News